Liver Cancer
Conditions
Brief summary
Spectral CT was used to prospectively collect medical images and clinical data related to liver cancer, evaluate the effect of image quality in the diagnosis of liver cancer, and evaluate the application value in the accurate staging of liver cancer, so as to provide a more accurate clinical basis for diagnosis, promote the development of individualized treatment, and ultimately improve the prognosis of patients.
Interventions
DIAGNOSTIC_TESTTo explore the value of spectral CT in the diagnosis and treatment of liver cancer
The CT scan is part of the standard treatment protocol.
Sponsors
Yunnan Cancer Hospital
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
1. Undergo a contrast-enhanced Quark Spectral CT scan of the lower abdomen/pelvis within 1 week before treatment. 2. Age \> 18 years. 3. Patients suspected of having liver cancer. 4. Patients who have signed the informed consent form.
Exclusion criteria
1. Severe cardiac, pulmonary, or renal insufficiency. 2. Allergy to iodine-based contrast agents. 3. Inability to cooperate with the CT examination. 4. Poor image quality of the Quark Spectral CT scan. 5. Women who are pregnant or breastfeeding.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pathological TNM staging | 1 day | Pathological examination information: The pathology results using surgery/biopsy data are the gold standard, and the depth of tumor invasion, lymph node metastasis, and distant metastasis are recorded |
Countries
China
Contacts
Primary ContactXumin Liu
Backup ContactZhenhui Li
Outcome results
None listed